BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 20, 2020
View Archived Issues
Nanoparticle fights pancreatic cancer's chemo resistance
Read More
FLUVID influenza-COVID-19 therapeutic cocktail demonstrates effective antiviral activity
Read More
Lumasiran approved in the E.U. for the treatment of PH1
Read More
First patient dosed in phase I study of SEFA-1024
Read More
Black Swan Pharmaceuticals patents antisense oligonucleotides targeting SOD1
Read More
New CD73 inhibitors discovered at Abbisko Therapeutics
Read More
Sotatercept for RV-PA coupling and RV function improvement in PAH
Read More
Sichuan Kelun-Biotech Biopharmaceutical identifies new STING agonists
Read More
New HBsAg and HBeAg secretion inhibitors discovered at Nanjing Hepo Pharmaceuticals
Read More
Jiangsu Carefree Pharmaceutical synthesizes new tyrosine kinase receptors inhibitors
Read More
Promore reports phase IIb data on ropocamptide for venous leg ulcers
Read More
Promising preclinical data for AK-119 as potential immunotherapy for COVID-19
Read More
Investigators plant better AID for protein degradation
Read More
Nourin-dependent miR-137 as early diagnostic biomarker for unstable angina
Read More
Phase III RATIONALE 303 trial of tislelizumab in NSCLC meets primary endpoint at interim analysis
Read More
IL-2-antibody fusion shows promising effects in metastatic melanoma and breast cancer murine models
Read More
FDA issues EUA for baricitinib with remdesivir for hospitalized COVID-19 patients
Read More
AVO-101: promising results for weight loss and NASH reduction
Read More
New trial evaluates F4 Pharma's FX-06 in patients with severe COVID-19
Read More
Novel mouse model allows efficacy evaluation of checkpoint inhibitors targeting CD28
Read More
Enrollment begins in registrational trial of Nyxol to reverse pharmacologically induced mydriasis
Read More